Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fascia Iliaca Block vs Fentanyl for Hip Fracture Positioning
NCT02037633Completed
- Sponsor
- Asklepieion Voulas General Hospital
- Start
- Jul 2012
- Primary completion
- Feb 2013
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
- Countries
- 1
01
Overview
Randomised, single-blind trial of ropivacaine hydrochloride liposomal suspension injection in hip fracture (2 arms), sponsored by Asklepieion Voulas General Hospital. Primary endpoint: Pain scores on the Numeric Rating Scale at 20 months. Started Jul 2012; status: completed.
02
Drugs
ropivacaine hydrochloride liposomal suspension injection
03
Conditions
hip fracture
Beyond the preview
Go deeper on NCT02037633.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02037633.